Additional information DISCLOSURE/CONFLICT OF INTEREST Michael Berk declares that over the past three years, he has received compensation from Stanley Medical Research Foundation, MBF, NHMRC, Beyond Blue, Geelong Medical Research Foundation, Bristol Myers Squibb, Eli Lilly, Glaxo SmithKline, Organon, Norvatis, Mayne Pharma and Servier
Researchers studying IBD models, mucosal repair, or gut-immune interactions benefit from KLOWs broader anti-inflammatory coverage compared to GLOW
Sterile water preparations should be used within 24-48 hours
PfGrx-dependent reduction kinetics for roGFP2 WT (S 2 ) To address the previously suggested alternative models for the glutaredoxin-dependent reduction of non-glutathione protein disulfides (Fig
Quality sleep patterns and regular exercise contribute to optimal nutrient delivery and cellular regeneration essential for robust hair growth
At 2.4 mg weekly, average weight loss reached about 15% over 68 weeks. Response varied widely: 86% lost at least 5%, 69% lost 10%, half lost 15%, and about one-third lost 20%. These results describe that cohort rather than a universal forecast